The Centre for Therapeutic Innovation (CTI) facilitates authentic collaboration between Pfizer scientists and select academic medical centres, disease foundations, and National Institutes of Health. Our aim is to translate promising science into clinical candidates. Pfizer Inc. has CTI labs in San Francisco, New York, Boston and San Diego.
These state-of-the-art laboratories are populated with Pfizer scientists and post-docs who are creating and advancing novel therapeutics, with the goal of moving the therapeutics rapidly into first-in-human proof of mechanism studies. CTI’s research collaborators work side-by-side with Pfizer scientists in the discovery and development of new therapies for unmet medical needs. For more information visit: https://www.pfizercti.com.